Gastroesophageal refl ux disease (GERD) is a common condition that affects patients ' healthrelated quality of life (HRQoL). The HRQoL of Barrett ' s esophagus (BE) has been less well studied. Furthermore, it is unknown to what extent BE patients suffer from psychological distress as a result of carrying a diagnosis of a premalignant condition. We sought to compare BE and GERD (stratifi ed by erosive refl ux disease (ERD) and non-erosive refl ux disease (NERD)) with regard to HRQoL and psychological impact.
INTRODUCTION
Gastroesophageal refl ux disease (GERD) is a common chronic disease, aff ecting 10 % -20 % of the American population on a regular basis (1) . Symptoms associated with GERD include heartburn, acid regurgitation, and chest pain, as well as " extraesophageal " manifestations such as nausea, chronic cough, asthma, and hoarseness. All of these symptoms may compromise health-related quality of life (HRQoL). In addition, sleep disturbance and associated daytime sleepiness, decrease in mealtime enjoyment, and increased medication costs may contribute to the burden of disease.
Barrett ' s esophagus (BE) is a metaplastic change associated with GERD, in which the normal squamous esophageal epithelium transforms into intestinal cells aft er chronic acidic insult from refl ux. Population studies demonstrate a prevalence of BE between 1 % -2 % (2,3) , but in patients with GERD symptoms, the prevalence of BE ranges from 10 % to 18 % (2,4) . BE is associated with a 30 -125-fold increased risk of adenocarcinoma compared with the general population (5, 6) . Although the relative risk of adenocarcinoma in patients with BE is quite high, their absolute risk remains low, approximately 0.5 % per patient per year (5) . Furthermore, cohort studies have generally not shown a decreased life expectancy in BE (7, 8) . Nonetheless, patients with BE may overestimate their individual cancer risk (9) , which could aff ect HRQoL and lead to deleterious psychological eff ects.
Th e negative eff ect of GERD alone on HRQoL and daily function has been examined in numerous studies (10 -12) . A smaller number of studies have investigated HRQoL in BE patients, documenting a similar decrement to that seen in GERD patients (13, 14) . Th eoretically, persons with GERD and BE are at risk for both the HRQoL decrease attributable to refl ux symptoms (i.e., that seen in GERD), as well as the psychological burden of carrying the diagnosis of a pre-cancerous lesion. However, it is unknown to what extent GERD symptoms are responsible for the decreased HRQoL observed in BE, as opposed to the contribution of the threat of cancer. Moreover, there are two diff erent manifestations of GERD: erosive refl ux disease (ERD) and non-erosive refl ux disease (NERD) (15) . Although their histological manifestation is less severe, NERD patients have been shown to have severe impairment in HRQoL (16) . NERD patients may have a psychological profi le similar to patients with functional bowel disease, who oft en have increased psychological distress (17) .
We carried out a cross-sectional analysis of data from a casecontrol study of BE and GERD patients to examine whether patients with BE have diff erent HRQoL than patients with ERD and NERD, aft er controlling for patient perception of GERD symptom severity. Th e aims of this study were to isolate any decrease in HRQoL associated with BE by comparing BE patients with GERD patients having similar GERD symptom severity, and to measure any additional psychological distress that may be associated with BE, which could potentially be attributed to cancer risk. In addition, we sought to determine whether any diff erences were present in quality of life based on gender and presence of erosive disease.
METHODS

Study subjects
Th e original study population was recruited over a 4-year period (2002 -2006 ) from consecutive patients aged 18 -80 years presenting for elective upper endoscopy at the Gastroenterology Endoscopy Clinic at the University of North Carolina with a primary or secondary indication of refl ux symptoms. Cases had both endoscopically and histologically confi rmed prevalent BE. All potential cases were solicited for enrollment. Controls were patients without BE but with classic GERD symptoms, consisting of substernal chest burning, regurgitation, and / or waterbrash syndrome, with a physician diagnosis of GERD. Th e control group was stratifi ed on the basis of the presence or absence of erosive disease, as verifi ed by esophagitis or erosions visualized on same-day endoscopy. As GERD patients outnumber BE patients by an estimated 9:1 ratio (4) , one-fourth of the eligible controls were randomly selected using a computer algorithm. An approximately 1:2 case to control ratio was used to improve the study power.
Patients were excluded if they could not read or comprehend the informed consent or questionnaires or did not speak English, had previously undergone partial or complete esophageal resection, had undergone endoscopic ablation of their BE, or were found to have esophageal carcinoma on the index endoscopy. Th e research protocol was reviewed and approved by the Institutional Review Board of the University of North Carolina.
Study measures
Medical outcomes study short form-36 (SF-36) . Th e SF-36 measures generic HRQoL, which allows comparisons between diff erent disease states. Th e SF-36 measures health status in eight domains: physical functioning, role limitations-physical, bodily pain, general health, vitality, social functioning, role limitations-emotional, and mental health. Two summary scores are also calculated from subject responses: the physical component score (PCS) and the mental component score (MCS) (18) .
Scores on the SF-36 range from 0 to 100 on each dimension and on the summary scales, with higher scores indicating better quality of life. Th e score is standardized in the general population with a mean of 50 and a s.d. of 10. Th e scale reliability ranges from 0.78 to 0.93 (18) . Th e SF-36 takes relatively little time to complete and has been validated across many populations. Data are available on patients with a wide range of conditions such as angina, clinical depression, congestive heart failure, diabetes, and hypertension (19) . A three-point diff erence on the summary scores is considered clinically meaningful in GERD (12) .
Gastrointestinal quality of life index (GIQLI)
. Th e GIQLI is a system-specifi c measure that has been used in multiple gastrointestinal disease states including GERD (20) . It assesses HRQoL in four domains: physical well-being, gastrointestinal symptoms, social well-being, and emotional well-being. Th e GIQLI is composed of 36 multiple-choice questions graded on
ESOPHAGUS
Quality of Life in GERD and Barrett ' s Esophagus a 0 -4 scale; the fi nal score is the sum of the question responses. Higher scores indicate less severe symptoms and improved HRQoL, and the maximum score is 144.
Th e revised Hopkins symptom checklist 90 (SCL-90-R)
. Th e SCL-90-R is a widely used measure of psychological distress. Th is instrument contains 90 questions addressing nine dimensions of symptoms: somatization (SOM), obsessive-compulsiveness, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychosis (21) . Th ere are also three summary measures including a global severity index (GSI), a positive symptom distress index and a positive symptom total. Th e questions are multiple-choice and graded on a 0 -4 scale, with higher scores indicating more distress.
On each scale of the SCL-90-R, results are expressed as t scores with a population mean of 50 and a s.d. of 10. General population norms are available for comparison with study population scores. A t -score of 60 corresponds to a relatively high level of psychological distress in the general population (approximately the 85 th percentile (22) . Th e SCL-90-R has previously been used to examine psychological distress in GERD patients but not in BE patients.
Th e gastroesophageal refl ux disease-health related quality of life questionnaire (GERD-HRQL)
. Th e GERD-HRQL was designed to measure patient perception of severity of symptoms of GERD. It is a 10-question instrument that examines the intensity and frequency of heartburn, diffi culty while swallowing, bloating, and the burden of GERD medication. Answers are graded from 1 to 5, with a maximum total score of 50 (23) . Higher scores correspond to more severe symptoms and worsened HRQoL. Th e GERD-HRQL has been found to be reliable and valid in a wide range of patient groups. We used this measure to control for patient-centered assessment of GERD symptom severity in our analysis.
Study outcomes
Th e primary outcomes of this study were quality of life and psychological distress, as measured with a generic quality of life instrument (SF-36), a disease-specifi c instrument (GIQLI), and a measure of psychological symptoms (SCL-90-R). We used the 10-item measure of GERD symptom severity, the GERD-HRQL, to control for the eff ect of GERD symptomatology on HRQoL. Results were stratifi ed by disease manifestation (BE vs. NERD vs. ERD).
Statistical analysis
Th is study was designed with >90 % power to calculate a 10 % diff erence in SF-36 summary scores with an alpha of 0.01.
Univariate statistics were used to examine means, s.d. and shapes of distributions for continuous variables and frequencies for categorical variables. Missing or extreme values were identifi ed and corrected as necessary; no data were imputed. Study participant test scores were eliminated if all questions on a test were answered with the same answer choice. For bivariate analysis, outcome measures were examined using t -tests for variables with two categories and one-way analysis of variance for variables with more than two categories.
Multiple linear regression was used to determine the relationship between GERD manifestation and HRQoL outcomes while controlling for potential confounding factors (age, gender, race, body mass index, current alcohol use, current smoking, current use of an anti-refl ux medication, comorbidity, and previous mental health diagnosis) and patient perception of GERD severity. Subjects with missing data on relevant variables were excluded from the multivariable analyses. As gender has previously been associated with diff erences in quality of life (24) , our analysis was repeated aft er stratifi cation by gender.
RESULTS
Participant characteristics
A total of 529 patients met entry criteria and were enrolled in the study. Th e characteristics of the study population are shown in Table 1 . Patients with BE were older, more commonly male and Caucasian, and more likely to have had anti-refl ux surgery as compared with the GERD patients. Th e non-erosive patients were more likely to be female as compared with the ERD and BE patients (64 % female vs. 42 % female and 33 % female, respectively). Alcohol and tobacco use were most common in the ERD group. Th ere was little diff erence between groups with respect to body mass index, current pharmacological treatment of GERD (e.g., with proton pump inhibitor or H2 blocker medication), comorbidities, or previous mental health diagnosis.
Outcome measures
Response rates . Th e GERD-HRQL questionnaire was completed by 395 out of 529 participants (74.7 % ), the SF-36 was completed by 374 out of 529 (70.7 % ), the GIQLI was completed by 365 out of 529 (69.0 % ), and the SCL-90R was completed by 391 out of 529 (73.9 % ). Response rates did not diff er between cases and controls.
Generic quality of life . Unadjusted results of the SF-36 summary scores stratifi ed by disease manifestation are shown in Table 2 . Th ere was a signifi cant diff erence between groups with respect to the MCS, with BE patients scoring on average three points higher than NERD or ERD patients (51.7 vs. 48.3 and 48.5 respectively, P = 0.02 for comparison). Although there was a slight improvement in the PCS in BE patients compared with controls, this was not statistically signifi cant ( P = 0.46).
Multivariate analysis adjusting for potential confounding variables (including symptom severity) demonstrated a similar diff erence between BE patients and GERD patients with respect to the MCS, but it was no longer statistically signifi cant ( Table 3 ) . Th ere was a signifi cant diff erence on the PCS in the adjusted model, however, with BE patients demonstrating a better PCS than both NERD patients (diff erence of 4.8, 95 % confi dence interval (CI) 0.8 -8.8) and ERD patients (diff erence of 7.1, 95 % CI 1.2 -13.1).
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physical functioning (role limitations-physical, general health, social functioning, and mental health), but these diff erences were not statistically signifi cant ( Figure 1 ).
Disease-specifi c quality of life . Unadjusted results from the GIQLI questionnaire in the three groups are shown in Table 2 .
Comparison of sub-domain results of the SF-36 demonstrated signifi cant diff erences between groups with respect to the bodily pain, vitality, and role limitations-emotional subscales, with BE patients scoring higher than both NERD and ERD patients indicating better HRQoL in these categories. Patients with BE had better HRQoL in all other subscales of the SF-36 apart from Psychological distress . We found no diff erence between groups with respect to GSI of the SCL-90R in either the unadjusted comparison ( Table 2 ) or the adjusted model ( Table 3 ). Scores on the nine dimensions and three summary measures of the scale are shown in Table 4 . Among the psychological dimensions of the SCL-90R, there was a small, but signifi cant diff erence between groups with respect to the SOM dimension, with BE patients scoring lower than ERD and NERD patients (58.3 vs. 59.7 and 57.4 respectively, P = 0.02). Th is indicates that BE patients may have less psychological distress related to SOM compared with GERD patients. However, given the lack of an overall diff erence in the GSI, multiple testing issues, and the relative instability of the dimension scores on the SCL-90R, these data must be viewed cautiously.
Role of symptom severity . Subjects with non-erosive disease were found to report worse patient assessment of GERD symptom severity than those with ERD or BE as measured by the GERD-HRQL (18.0 vs. 15.9 and 13.7 respectively, P < 0.01) ( Table 2 ). When we controlled for patient perception of symptom severity by adding GERD-HRQL into the regression model, patients with BE continued to show a signifi cantly better disease-specifi c quality of life than NERD patients, as 
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When stratifi ed by gender, both male and female NERD patients reported worse generic (SF-36) and disease-specifi c HRQoL (GIQLI) than ERD and BE patients of the same sex. Women had worse gastrointestinal-specifi c quality of life than men in both the NERD and BE groups, and worse generic HRQoL in the ERD group. As there were more women in the NERD group, it appears that the worsened HRQoL in the NERD group is partially confounded by gender. However, when we controlled for other variables including gender, the diff erence in HRQoL between NERD and ERD or BE patients remained statistically signifi cant.
Overall, these fi ndings suggest that the HRQoL decrement in BE is related to loss-of-function secondary to physical symptoms, but not psychological distress. It is possible that patients with NERD may actually have functional esophageal disease with a prominent psychological component. Th e patients with NERD reported signifi cantly worse HRQoL on almost all measures examined in this study. Th ese fi ndings can be attributed to perceiving symptoms as more severe and being more refractory to treatment. As BE patients presumably had true acidic insults to their esophagus in the past to have undergone metaplasia, the NERD patients might be expected to have the best HRQoL, as their disease manifestation would be the least severe; on the contrary, these subjects showed the worst quality of life. In addition, women in each group were observed to have worse quality of life than men on most study measures. Improved HRQoL in BE patients may be because of fewer symptoms, as some authors have described (25) . A recent population study estimated that up to 46 % of BE patients may be asymptomatic (26) . However, this observation persisted aft er we controlled for symptom severity. Th erefore, we hypothesize that the trends reported here are due to a heightened sensitivity and symptom perception of patients with NERD.
As compared with the general population, patients with GERD and BE in this study report worse quality of life on every dimension of the SF-36, with scores that are comparable to patients with diabetes and clinical depression (18) . HRQoL in BE patients has been assessed by other investigators. Kulig et al . (14) reported SF-36 summary score results on 702 German patients with BE, 2660 ERD patients, and 2853 NERD patients . Th e reported PCS and MCS scores for BE patients were 42.6 and 46.2 respectively, similar to our fi ndings of 41.8 and 51.7. It is interesting to note that results for NERD patients were higher for the PCS (43.5 vs. 40.0) and lower for the MCS (43.9 vs. 48.3) compared with our fi ndings. Eloubedi et al . (13) conducted a study of 107 patients with BE and 104 with GERD but without BE using the SF-36 and the quality of life in refl ux and dyspepsia questionnaire . A measure of symptom severity was also used, but was not controlled for in a multivariate regression model comparing groups. Th e authors reported no signifi cant diff erences between groups with respect to either HRQoL measure. Two studies have reported GIQLI scores on BE patients in the 94 -96 range, but both were in the pre-operative setting before Nissen fundoplication. Th erefore, patients would be expected to be suff ering from more severe symptoms than the average BE patient, which may explain the measured by the GIQLI (137.7 vs. 125.5, diff erence = 12.2, 95 % CI = 5.1 -19.3). In addition, BE patients demonstrated improved generic HRQoL, as measured by the PCS measure of the SF-36, when compared with NERD patients (44.6 vs. 39.8, diff erence = 4.8, 95 % CI = 0. 8 -8.8) . Th e improved SF-36 summary score for BE patients represents a clinically meaningful diff erence, given that it is greater than 3.0. Th ere were no signifi cant diff erences between ERD and NERD patients on any of the HRQoL or psychological distress summary measures, nor were there diff erences between the BE and NERD patients in terms of psychological distress (as measured by the SCL-90R GSI) ( Table 3 ).
Role of gender . Aft er stratifying by gender, males with BE reported lower symptom severity than males with GERD. Th is trend was similar in females, but it did not reach statistical signifi cance ( Figure 2 ). Women reported signifi cantly worse gastrointestinal-specifi c quality of life in both the NERD and BE groups as compared with men in these groups ( Supplementary Table online, Figure 3 ). Both men and women with NERD had worsened GIQLI scores compared with ERD and BE patients of the same gender. Men with ERD had higher SF-36 PCS scores than women with ERD, but otherwise, there were no signifi cant diff erences between genders with respect to SF-36 summary scores, or SCL-90R GSI.
DISCUSSION
Our study showed there are diff erences in HRQoL based on GERD manifestation. Patients with BE generally had better HRQoL than those with NERD or ERD. Aft er adjusting for symptom severity, this diff erence was statistically signifi cant as measured by the GIQLI, and the SF-36 physical component summary. Th ere were few diff erences between groups with respect to the SCL-90-R; apart from the fi nding that BE patients had somewhat less somatization than other groups. diff erence compared with our GIQLI mean of 137.2. One study that used the SCL-90 in GERD patients reported higher scores on dimensions of SOM, obsessiveness, interpersonal sensitivity, phobia, psychosis, and the GSI compared with healthy controls (27, 28) . Although no studies have been done previously using the SCL-90R in BE patients, several studies have used the Hospital Anxiety and Depression scale to evaluate psychological symptoms. A study of BE patients in an endoscopic surveillance program reported that BE patients had higher anxiety scores than the general population, but a second study demonstrated only minimal depression and anxiety for BE patients on the Hospital Anxiety and Depression scale (29, 30) . Our study has several strengths. We assessed a large number of patients with various manifestations of GERD. Previously validated tools were used to assess HRQoL and psychological stress. It is important to note that we were able to control for several possible confounders including a patient assessment of GERD symptom severity, which has not been done in past investigations. GERD manifestation was assessed with sameday endoscopy, minimizing misclassifi cation.
Several limitations can also be described. All patients in the study were presenting to a single tertiary care center and may not refl ect the population of GERD patients treated in the community. In addition, our study population was primarily white, which refl ects the overall BE population but may limit the generalizability to patients of diff erent races. It is important to note that though the parent study was a case -control design, our study measured HRQoL and psychological distress at one point in time, so that temporality of HRQoL decrements in relationship to the time of diagnosis cannot be fi rmly established. Also, as we did not demand the cessation of acid-suppressive medication before endoscopy, our NERD group was likely " contaminated " with treated erosive disease. It is important to note however, that if diff erential misclassifi cation of ERD subjects into the NERD group occurred, the eff ect would tend to minimize, not accentuate, the diff erences in HRQoL we report between the NERD and ERD groups. As pH testing was not a part of this study, the NERD group could also contain patients with typical GERD symptoms but without actual refl ux (e.g., patients with functional heartburn). Nevertheless, such testing is uncommon for GERD patients in practice, and this group was representative of the typical NERD patients seen at our institution, contributing to the external validity of our results.
In addition, there are limitations due to the use of multiple HRQoL measurement tools. As each participant was asked to fi ll out four diff erent multi-item questionnaires, we did have missing data for each measure. Th ough response rates were similar between cases and controls, patients who completed the HRQoL assessments may still diff er from those who did not do so. Also, because of the nature of the HRQoL measurements used and the preponderance of subscales for each measure (17 for the SF-36 and SCL-90R combined), some statistically signifi cant diff erences between subscales may be a consequence of multiple testing. However, consistent trends amongst subscales favoring improved HRQoL on the SF-36 and less psychological distress SCL-90R for BE patients add validity to the individual subscale diff erences. Furthermore, the fi nding that NERD patients have the most SOM is supported by previous studies, assuming that functional heartburn patients are included in this category (17) . Nevertheless, because of multiple testing concerns, our a priori hypothesis testing focused on the summary measure comparisons, and we carried out pairwise comparisons only if one-way analysis of variance testing was signifi cant. Th erefore, our main fi ndings in BE patients of reduced symptom severity, improved disease-specifi c HRQoL, and improved generic HRQoL as measured by SF-36 summary measures are minimally aff ected by multiple testing.
In summary, our study showed that patients with GERD have worse quality of life than patients with BE, even aft er controlling for GERD symptoms. When stratifi ed, females have worse quality of life than males. In addition, patients with GERD symptoms and NERD have higher levels of psychological distress. Future studies are indicated to further examine the psychological component of NERD, and eff orts should be directed at improving HRQoL in this disorder. In addition, more precise instruments may aid in detecting any HRQoL decrements in BE patients because of perceived cancer risk or fear of developing or dying from cancer.
